Showing results (61-70 of 113) with videos related to
Sort By:
Pageof 12
Clinical Chemistry|November 13, 2004
Effects of processing and storage conditions on amyloid beta (1-42) and tau concentrations in cerebrospinal fluid: implications for use in clinical practiceNiki S M Schoonenboom, Cees Mulder, Hugo Vanderstichele, et al.Prenatal Diagnosis|March 5, 2008
Decreased plasma levels of metastin in early pregnancy are associated with small for gestational age neonatesEva M L Smets, Koen L Deurloo, Attie T J I Go, et al.Clinical Chemistry and Laboratory Medicine|February 24, 2011
Tau and p-tau as CSF biomarkers in dementia: a meta-analysisArgonde C van Harten, Maartje I Kester, Pieter-Jelle Visser, et al.Neurobiology of Aging|November 29, 2011
Microbleeds relate to altered amyloid-β metabolism in Alzheimer's diseaseJeroen D C Goos, Charlotte E Teunissen, Robert Veerhuis, et al.Journal of Alzheimer'S Disease : JAD|September 25, 2015
Clusterin Levels in Plasma Predict Cognitive Decline and Progression to Alzheimer's DiseaseWesley Jongbloed, Karin D van Dijk, Sandra D Mulder, et al.Neurobiology of Aging|April 17, 2013
Alzheimer's disease patients not carrying the apolipoprotein E ε4 allele show more severe slowing of oscillatory brain activityHanneke de Waal, Cornelis J Stam, Willem de Haan, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 13, 2012
Cerebrospinal fluid Aβ42 is the best predictor of clinical progression in patients with subjective complaintsArgonde C van Harten, Pieter Jelle Visser, Yolande A L Pijnenburg, et al.Clinical Chemistry|October 17, 2009
Amyloid-beta(1-42), total tau, and phosphorylated tau as cerebrospinal fluid biomarkers for the diagnosis of Alzheimer diseaseCees Mulder, Nicolaas A Verwey, Wiesje M van der Flier, et al.Molecular Medicine Reports|April 12, 2011
Novel cerebrospinal fluid biomarkers of axonal degeneration in frontotemporal dementiaNiklas Mattsson, Ulla Rüetschi, Yolande A L Pijnenburg, et al.Journal of Alzheimer'S Disease : JAD|December 31, 2014
Amyloid-β oligomers relate to cognitive decline in Alzheimer's diseaseWesley Jongbloed, Kim A Bruggink, Maartje I Kester, et al.Pageof 12